[
    [
        {
            "time": "",
            "original_text": "上海莱士(002252.SZ)：与深圳熹丰就股权转让合同中剩余转让款的履行事宜达成和解",
            "features": {
                "keywords": [
                    "上海莱士",
                    "深圳熹丰",
                    "股权转让",
                    "和解"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物制品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "上海莱士(002252.SZ)：与深圳熹丰就股权转让合同中剩余转让款的履行事宜达成和解",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "上海莱士：郑州莱士与深圳熹丰因股权转让合同纠纷和解 资产异常",
            "features": {
                "keywords": [
                    "上海莱士",
                    "郑州莱士",
                    "深圳熹丰",
                    "股权转让",
                    "纠纷和解",
                    "资产异常"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物制品"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "上海莱士：郑州莱士与深圳熹丰因股权转让合同纠纷和解 资产异常",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "股价闪崩8%！华兰生物业绩远低预期，批签发数据早有苗头 盈利能力下降",
            "features": {
                "keywords": [
                    "华兰生物",
                    "股价闪崩",
                    "业绩低预期",
                    "批签发数据",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物制品"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "股价闪崩8%！华兰生物业绩远低预期，批签发数据早有苗头 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "血液中的\"黄金救命药\"何时实现工业化生产？ ——重组人血清白蛋白的研发进展",
            "features": {
                "keywords": [
                    "血液",
                    "黄金救命药",
                    "工业化生产",
                    "重组人血清白蛋白",
                    "研发进展"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物制品"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "血液中的\"黄金救命药\"何时实现工业化生产？ ——重组人血清白蛋白的研发进展",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]